Forget Oil. New Wildcatters Are Drilling For Limitless 'Geologic' Hydrogen | MedTech Billionaire vs. Apple's Patent Battle | Prostate Cancer Radiotherapy Trial Success | Joe Biden's Pro-Union Stance and Potential Regrets

View online | Unsubscribe (one-click).
For inquiries/unsubscribe issues, Contact Us

?

?

?

?

?

?

Forget Oil. New Wildcatters Are Drilling For Limitless ‘Geologic’ Hydrogen - Forbes

The push to wean the planet off carbon-free fuels and transition to renewable energy has focused mainly on wind and solar power. But mounting scientific evidence suggests there's an untapped clean energy source deep underground that could provide vastly more power than we need: hydrogen created by natural geologic processes. And like the oil industry's early days in the 19th century, it's spawning a wave of drilling startups vying to be first to find big deposits.

"View them like oil wildcatters right now," Doug Wicks, a program director for the U.S. Energy Department's Advanced Research Projects Agency-Energy, told Forbes, equating hydrogen hunters to traditional drillers scouting for petroleum in new fields. Globally, he says the amount of geologic hydrogen may be "astronomical" based on how common the geologic conditions needed to generate it appear to be: Iron-rich pockets of water near tectonic rifts, located worldwide.

Potentially, "it's 150 trillion metric tons," Wicks said. "One billion tons would power the United States for a full year."

Continued here

?

?

?

?

?

?

Don't like ads? Go ad-free with TradeBriefs Premium

Want to accelerate software development at your company? See how we can help.

The MedTech Billionaire Waging A Patent War With Apple - Forbes

In May 2013, Joe Kiani, the founder and CEO of medical technology company Masimo, went to a meeting at Apple’s headquarters in Cupertino to discuss a potential collaboration. The consumer technology giant was in the process of developing the Apple Watch and exploring ways to incorporate different health sensors. Founded in 1989, Masimo is best known for its pulse oximeters – fingertip devices used by hospitals to measure the level of oxygen in patients’ blood. “I didn't want to be in the consumer space ourselves,” says Kiani. “I thought Apple would be a great partner to take our technology and make it available to the masses.”

Masimo was one of 28 companies that Apple met with related to the Apple Watch project. Internally, Apple executives were weighing a potential Masimo acquisition, but ultimately decided against it because Masimo’s hospital-focused products were outside of Apple’s core consumer focus. “Acquisitions of this size aren’t our style,” Adrian Perica, Apple’s vice president of corporate development wrote in an email update to CEO Tim Cook.

Ten years later, Apple and the company it rejected are embroiled in a multi-front legal battle over the Apple Watch. Apple commands over 56% of the global smartwatch market, which is expected to hit $33 billion in 2023, according to research firm IDC. The firm forecasts the larger global wearables market will hit nearly $63 billion.

Continued here

?

?

?

?

?

?

Radiotherapy doses for prostate cancer could be cut by three-quarters, trial finds - the Guardian

Five higher multibeam doses found to be as effective as 20 smaller doses delivered over several weeks

Men undergoing treatment for prostate cancer could be safely exposed to fewer radiotherapy sessions, a big trial has found.

The trial, conducted by the Royal Marsden NHS foundation trust and the Institute of Cancer Research in London, found that radiotherapy doses can be cut by three-quarters, meaning that five higher doses of radiotherapy are just as effective as 20 smaller doses delivered over several weeks.

Continued here

?

?

?

?

?

?

Joe Biden may come to regret his claim to be pro-union - The Economist

Both the Democratic and Republican parties are already fairly sure who their nominees will be in 2024, so the general election campaign will begin unusually early. Perhaps it started this week: President Joe Biden joined a picket line in Michigan, becoming the first sitting president to do so; the next day Donald Trump was in the same state, also courting car workers. As befits a campaign in which the two candidates have a combined age of 157, it has a retro feel. High inflation and striking union workers in Detroit recall races from the 1970s.

The United Auto Workers Union (UAW) wants a 36% pay increase over four years, better pensions, health care for those who have retired and sweeter terms for those hired since two of the “big three” carmakers received a federal bail-out in 2008 (one of them is Stellantis, whose biggest shareholder part-owns The Economist’s parent company). That is a lot to ask, particularly given that the labour market is softer than a year ago. Average pay and benefits at the big three in Detroit currently range from $112,000 a year at Ford to $134,000 at GM. The unions counter that the firms are making record profits and ceo pay has soared. However, this is a cyclical business that seems to be at a high point: demand that built up when supply chains were disrupted is keeping prices unusually high.

None of this matters much to Mr Trump or Mr Biden, whose focus is on 2024. Mr Trump promises to protect manufacturing workers with tariffs. So does Mr Biden in a more targeted way, to accompany subsidies he has introduced to encourage electric vehicles (evs). Both hope to appeal to working-class families in the Midwest, home to two of next year’s six swing states.

Continued here

?

?

?

?

?

?

You are receiving this mailer as a TradeBriefs subscriber.
We fight fake/biased news through human curation & independent editorials.
Your support of ads like these makes it possible. Alternatively, get TradeBriefs Premium (ad-free) for only $2/month
If you still wish to unsubscribe, you can unsubscribe from all our emails here
Our address is 309 Town Center 1, Andheri Kurla Road, Andheri East, Mumbai 400059 - 93544947